Steven L. Hoerter - Apr 7, 2025 Form 4 Insider Report for MBX Biosciences, Inc. (MBX)

Role
Director
Signature
/s/ Richard Bartram, attorney-in-fact
Stock symbol
MBX
Transactions as of
Apr 7, 2025
Transactions value $
$0
Form type
4
Date filed
4/9/2025, 08:27 AM
Previous filing
Jan 6, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MBX Stock option (right to buy) Award $0 +32K $0.00 32K Apr 7, 2025 Common Stock 32K $6.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-third of the shares underlying this option will vest and become exercisable on April 7, 2026, the anniversary of the date of grant, with the remainder vesting monthly over the subsequent two year period, subject to the Reporting Person's continued service on each such vesting date.